Exclusive increase of CX3CR1+CD28-CD4+ T cells in inflammatory bowel disease and their recruitment as intraepithelial lymphocytes

Taku Kobayashi, Susumu Okamoto, Yuko Iwakami, Atsushi Nakazawa, Tadakazu Hisamatsu, Hiroshi Chinen, Nobuhiko Kamada, Toshio Imai, Hidemi Goto, Toshifumi Hibi

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

Background: CX3CL1/Fractalkine (FKN) has been reported to play important roles in various inflammatory diseases. We examined the role of FKN and its receptor CX3CR1 in T-cell migration in the inflammatory bowel diseases (IBDs), ulcerative colitis (UC) and Crohn's disease (CD). Methods: CX3CR1 expression on peripheral CD4+ cells from normal controls (NL n = 24) and IBD patients (UC n = 28, CD n = 26) was examined using flow cytometry. CX3CR1 +CD4+ T cells were further characterized for surface antigens, cytokine production, and cytotoxic granule release by flow cytometry and ELISA. FKN expression in 53 colonic biopsy specimens (UC n = 20, CD n = 23, NL n = 10) was analyzed by quantitative PCR and immunohistochemistry. Isolated lamina propria and intraepithelial lymphocytes were also analyzed by flow cytometry (UC n = 10, CD n = 10, NL n = 6). Results: CX3CR1+CD4 + cells were increased in IBD while they were virtually absent in controls. Upregulation of CX3CR1 on CD4+ T cells was positively correlated with disease activity. These unique T cells expressed markers for both effector memory and cytotoxic cells. Interestingly, CX3CR1 was expressed on CD4+ T cells lacking CD28. CX3CR1+CD28 -CD4+ cells produced more IFN-γ and TNF-α than CX3CR1- counterparts and released cytotoxic granules. FKN mRNA was upregulated in inflamed colonic tissues and robust expression of FKN was immunohistochemically observed on epithelial cells. Although CX3CR1+ CD4+ cells could not be detected in the gut, CD28-CD4 + cells were found in IBD mainly as intraepithelial lymphocytes. Conclusions: FKN/CX3CR1 may contribute to the pathogenesis of IBD through the emergence of unique CX3CR1+CD28-CD4+ T cells that can act both as proinflammatory and cytotoxic cells.

Original languageEnglish
Pages (from-to)837-846
Number of pages10
JournalInflammatory Bowel Diseases
Volume13
Issue number7
DOIs
Publication statusPublished - 2007 Jul

Fingerprint

Chemokine CX3CL1
Inflammatory Bowel Diseases
Lymphocytes
T-Lymphocytes
Ulcerative Colitis
Crohn Disease
Flow Cytometry
Surface Antigens
Cell Movement
Mucous Membrane
Up-Regulation
Epithelial Cells
Enzyme-Linked Immunosorbent Assay
Immunohistochemistry
Cytokines
Biopsy
Polymerase Chain Reaction
Messenger RNA

Keywords

  • CD28
  • CD4
  • CX3CR1
  • Fractalkine
  • Inflammatory bowel disease

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Exclusive increase of CX3CR1+CD28-CD4+ T cells in inflammatory bowel disease and their recruitment as intraepithelial lymphocytes. / Kobayashi, Taku; Okamoto, Susumu; Iwakami, Yuko; Nakazawa, Atsushi; Hisamatsu, Tadakazu; Chinen, Hiroshi; Kamada, Nobuhiko; Imai, Toshio; Goto, Hidemi; Hibi, Toshifumi.

In: Inflammatory Bowel Diseases, Vol. 13, No. 7, 07.2007, p. 837-846.

Research output: Contribution to journalArticle

Kobayashi, T, Okamoto, S, Iwakami, Y, Nakazawa, A, Hisamatsu, T, Chinen, H, Kamada, N, Imai, T, Goto, H & Hibi, T 2007, 'Exclusive increase of CX3CR1+CD28-CD4+ T cells in inflammatory bowel disease and their recruitment as intraepithelial lymphocytes', Inflammatory Bowel Diseases, vol. 13, no. 7, pp. 837-846. https://doi.org/10.1002/ibd.20113
Kobayashi, Taku ; Okamoto, Susumu ; Iwakami, Yuko ; Nakazawa, Atsushi ; Hisamatsu, Tadakazu ; Chinen, Hiroshi ; Kamada, Nobuhiko ; Imai, Toshio ; Goto, Hidemi ; Hibi, Toshifumi. / Exclusive increase of CX3CR1+CD28-CD4+ T cells in inflammatory bowel disease and their recruitment as intraepithelial lymphocytes. In: Inflammatory Bowel Diseases. 2007 ; Vol. 13, No. 7. pp. 837-846.
@article{d0d03de1180d426583a5c31c5e973ac6,
title = "Exclusive increase of CX3CR1+CD28-CD4+ T cells in inflammatory bowel disease and their recruitment as intraepithelial lymphocytes",
abstract = "Background: CX3CL1/Fractalkine (FKN) has been reported to play important roles in various inflammatory diseases. We examined the role of FKN and its receptor CX3CR1 in T-cell migration in the inflammatory bowel diseases (IBDs), ulcerative colitis (UC) and Crohn's disease (CD). Methods: CX3CR1 expression on peripheral CD4+ cells from normal controls (NL n = 24) and IBD patients (UC n = 28, CD n = 26) was examined using flow cytometry. CX3CR1 +CD4+ T cells were further characterized for surface antigens, cytokine production, and cytotoxic granule release by flow cytometry and ELISA. FKN expression in 53 colonic biopsy specimens (UC n = 20, CD n = 23, NL n = 10) was analyzed by quantitative PCR and immunohistochemistry. Isolated lamina propria and intraepithelial lymphocytes were also analyzed by flow cytometry (UC n = 10, CD n = 10, NL n = 6). Results: CX3CR1+CD4 + cells were increased in IBD while they were virtually absent in controls. Upregulation of CX3CR1 on CD4+ T cells was positively correlated with disease activity. These unique T cells expressed markers for both effector memory and cytotoxic cells. Interestingly, CX3CR1 was expressed on CD4+ T cells lacking CD28. CX3CR1+CD28 -CD4+ cells produced more IFN-γ and TNF-α than CX3CR1- counterparts and released cytotoxic granules. FKN mRNA was upregulated in inflamed colonic tissues and robust expression of FKN was immunohistochemically observed on epithelial cells. Although CX3CR1+ CD4+ cells could not be detected in the gut, CD28-CD4 + cells were found in IBD mainly as intraepithelial lymphocytes. Conclusions: FKN/CX3CR1 may contribute to the pathogenesis of IBD through the emergence of unique CX3CR1+CD28-CD4+ T cells that can act both as proinflammatory and cytotoxic cells.",
keywords = "CD28, CD4, CX3CR1, Fractalkine, Inflammatory bowel disease",
author = "Taku Kobayashi and Susumu Okamoto and Yuko Iwakami and Atsushi Nakazawa and Tadakazu Hisamatsu and Hiroshi Chinen and Nobuhiko Kamada and Toshio Imai and Hidemi Goto and Toshifumi Hibi",
year = "2007",
month = "7",
doi = "10.1002/ibd.20113",
language = "English",
volume = "13",
pages = "837--846",
journal = "Inflammatory Bowel Diseases",
issn = "1078-0998",
publisher = "John Wiley and Sons Inc.",
number = "7",

}

TY - JOUR

T1 - Exclusive increase of CX3CR1+CD28-CD4+ T cells in inflammatory bowel disease and their recruitment as intraepithelial lymphocytes

AU - Kobayashi, Taku

AU - Okamoto, Susumu

AU - Iwakami, Yuko

AU - Nakazawa, Atsushi

AU - Hisamatsu, Tadakazu

AU - Chinen, Hiroshi

AU - Kamada, Nobuhiko

AU - Imai, Toshio

AU - Goto, Hidemi

AU - Hibi, Toshifumi

PY - 2007/7

Y1 - 2007/7

N2 - Background: CX3CL1/Fractalkine (FKN) has been reported to play important roles in various inflammatory diseases. We examined the role of FKN and its receptor CX3CR1 in T-cell migration in the inflammatory bowel diseases (IBDs), ulcerative colitis (UC) and Crohn's disease (CD). Methods: CX3CR1 expression on peripheral CD4+ cells from normal controls (NL n = 24) and IBD patients (UC n = 28, CD n = 26) was examined using flow cytometry. CX3CR1 +CD4+ T cells were further characterized for surface antigens, cytokine production, and cytotoxic granule release by flow cytometry and ELISA. FKN expression in 53 colonic biopsy specimens (UC n = 20, CD n = 23, NL n = 10) was analyzed by quantitative PCR and immunohistochemistry. Isolated lamina propria and intraepithelial lymphocytes were also analyzed by flow cytometry (UC n = 10, CD n = 10, NL n = 6). Results: CX3CR1+CD4 + cells were increased in IBD while they were virtually absent in controls. Upregulation of CX3CR1 on CD4+ T cells was positively correlated with disease activity. These unique T cells expressed markers for both effector memory and cytotoxic cells. Interestingly, CX3CR1 was expressed on CD4+ T cells lacking CD28. CX3CR1+CD28 -CD4+ cells produced more IFN-γ and TNF-α than CX3CR1- counterparts and released cytotoxic granules. FKN mRNA was upregulated in inflamed colonic tissues and robust expression of FKN was immunohistochemically observed on epithelial cells. Although CX3CR1+ CD4+ cells could not be detected in the gut, CD28-CD4 + cells were found in IBD mainly as intraepithelial lymphocytes. Conclusions: FKN/CX3CR1 may contribute to the pathogenesis of IBD through the emergence of unique CX3CR1+CD28-CD4+ T cells that can act both as proinflammatory and cytotoxic cells.

AB - Background: CX3CL1/Fractalkine (FKN) has been reported to play important roles in various inflammatory diseases. We examined the role of FKN and its receptor CX3CR1 in T-cell migration in the inflammatory bowel diseases (IBDs), ulcerative colitis (UC) and Crohn's disease (CD). Methods: CX3CR1 expression on peripheral CD4+ cells from normal controls (NL n = 24) and IBD patients (UC n = 28, CD n = 26) was examined using flow cytometry. CX3CR1 +CD4+ T cells were further characterized for surface antigens, cytokine production, and cytotoxic granule release by flow cytometry and ELISA. FKN expression in 53 colonic biopsy specimens (UC n = 20, CD n = 23, NL n = 10) was analyzed by quantitative PCR and immunohistochemistry. Isolated lamina propria and intraepithelial lymphocytes were also analyzed by flow cytometry (UC n = 10, CD n = 10, NL n = 6). Results: CX3CR1+CD4 + cells were increased in IBD while they were virtually absent in controls. Upregulation of CX3CR1 on CD4+ T cells was positively correlated with disease activity. These unique T cells expressed markers for both effector memory and cytotoxic cells. Interestingly, CX3CR1 was expressed on CD4+ T cells lacking CD28. CX3CR1+CD28 -CD4+ cells produced more IFN-γ and TNF-α than CX3CR1- counterparts and released cytotoxic granules. FKN mRNA was upregulated in inflamed colonic tissues and robust expression of FKN was immunohistochemically observed on epithelial cells. Although CX3CR1+ CD4+ cells could not be detected in the gut, CD28-CD4 + cells were found in IBD mainly as intraepithelial lymphocytes. Conclusions: FKN/CX3CR1 may contribute to the pathogenesis of IBD through the emergence of unique CX3CR1+CD28-CD4+ T cells that can act both as proinflammatory and cytotoxic cells.

KW - CD28

KW - CD4

KW - CX3CR1

KW - Fractalkine

KW - Inflammatory bowel disease

UR - http://www.scopus.com/inward/record.url?scp=34547633802&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547633802&partnerID=8YFLogxK

U2 - 10.1002/ibd.20113

DO - 10.1002/ibd.20113

M3 - Article

C2 - 17285595

AN - SCOPUS:34547633802

VL - 13

SP - 837

EP - 846

JO - Inflammatory Bowel Diseases

JF - Inflammatory Bowel Diseases

SN - 1078-0998

IS - 7

ER -